October 23, 2030 — Global medical devices and solutions provider Mindray has announced the introduction and global launch of two new high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers.

October 23, 2023 — Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence (AI) algorithm can detect an abnormal heart rhythm in people not yet showing symptoms. 

October 23, 2023 — Supira Medical, Inc., a Shifamed portfolio company, announced that the company's percutaneous ventricular assist device (pVAD) will be showcased in multiple sessions, including a live case presentation, during the 2023 Transcatheter Cardiovascular Therapeutics (

October 20, 2023 — JenaValve Technology, Inc., developer and manufacturer of the Trilogy Transcatheter Heart Valve (THV) System, announced that data from the ALIGN-AR Pivotal Trial will be presented by Dr.

October 20, 2023 —  Over the coming days, Philips will be presenting its latest solutions in cardiology and new late-breaking clinical data at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting (October 23-26 in San Francisco, USA). Philips will feature a comprehensive portfolio of image-guided therapy and echocardiography solutions that integrate advanced imaging systems and software with specialized diagnostic and therapeutic devices, creating a holistic approach to support high-quality treatment, even for complex medical procedures.

October 20, 2023 — An international team of scientists has identified nearly a dozen genes that contribute to calcium buildup in our coronary arteries that can lead to life-threatening coronary artery disease, a condition responsible for up to one in four deaths in the United States.

Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26

Innovation. Connection. Inspiration.

October 19, 2023 — The Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for use in atrial transseptal procedures and delivery of catheters, has now been successfully used in 15 human cases, at major cardiology hospitals in Arizona and Minnesota. 

October 19, 2023 — Edwards Lifesciences Corporation announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter treatment of eligible patients with tricuspid regurgitation (TR).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now